2BB score and signals
Innate Pharma SA’s current 2BB score is 17 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 30 | Low |
Innate Pharma SA (IPHA) Stock Score & Signals
Innate Pharma SA (IPHA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 17 out of 100.
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.0606 | — | $2.33M |
| 2026-09-17 | — | -0.0707 | — | $8.08M |